t(9;14)(p13;q32) involving the PAX-5 gene: A unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma

International Journal of Hematology

Volumn 69, Issue 2, 1999, Pages 65-69

  Amakawa, Ryuichi ^a   Ohno, Hitoshi ^b   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

14q32 translocation; Deregulation; Lymphoplasmacytic lymphoma; PAX 5 gene; t(9; 14)(p13; q32)

Indexed keywords

DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PAX5 PROTEIN, HUMAN; PAX5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; TUMOR PROTEIN;

ANIMAL; B CELL LYMPHOMA; CELL TRANSFORMATION; CHROMOSOME 14; CHROMOSOME 9; CHROMOSOME PAINTING; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; HOMEOBOX; HUMAN; MOLECULAR CLONING; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 9; CLONING, MOLECULAR; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0033069482     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fukuhara S, Uchino H. Subclasses of 14q+ marker-positive lymphoid cancer. N Engl J Med 1983;308:1603-4.
2. Kamesaki H, Miwa H, Ohno Y, et al. A novel B cell line established from Ki-1-positive diffuse large cell lymphoma. Jpn J Cancer Res 1988;79:1193-200.
3. Offit K, Parsa NZ, Filippa D, et al. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 1992;80:2594-9.
4. Lennert K, Feller A. Histopathology of Non-Hodgkin's Lymphomas. New York: Springer-Verlag, 1992.
5. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
6. Kawakami K, Amakawa R, Miyanishi S, et al. A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32). Int J Hematol 1998;67:191-8.
7. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol in press
8. Ohno H, Furukawa T, Fukuhara S, et al. Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen. Proc Natl Acad Sci USA 1990;87:628-32.
9. Iida S, Rao PH, Nallasivam P, et al.The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996;88:4110-17.
10. Busslinger M, Klix N, Pfeffer P, et al. Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promotors in a diffuse large-cell lymphoma. Proc Natl Acad Sci USA 1996;93:6129-34.
11. Hamada T, Yonetani N, Ueda C, et al. Expression of PAX5/BSAP transcription factor in haematological tumor cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma. Br J Haematol 1998;102:691-700.
12. Busslinger M, Urbanek P. The role of BSAP (PAX-5) in B-cell development. Curr Opin Genet Dev 1995;5:595-601.
13. Neurath MF, Stuber ER, Strober W. BSAP:a key regulator of B-cell development and differentiation. Immunol Today 1995;16:564-9.
14. Tsujimoto Y, Cossman L, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-3.
15. Cleary ML, Galili N, Sklar J. Detection of a second t(14;18) break-point cluster region in human follicular lymphomas. J Exp Med 1986;164:315-20.
16. Tsujimoto Y, Bashir MM, Givol I, et al. DNA rearrangements in human follicular lymphoma can involve the 5′ or the 3′ region of the bcl-2 gene. Proc Natl Acad Sci U S A 1987;84:1329-31.
17. Mills FC, Harindranath N, Mitchell M, et al. Enhancer complexes located downstream of both human immunoglobulin C alpha genes. J Exp Med 1997;186:845-58.
18. Chen C, Birshtein BK. Virtually identical enhancers containing a segment of homology to murine 3′ IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes. J Immunol 1997;159:1310-18.
19. Tycko B, Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 1990;2:1-8.
20. Wyatt RT, Rudders RA, Zelenetz A, et al. BCL2 oncogene translocation is mediated by a x-like consensus. J Exp Med 1992;175:1575-88.
21. Adams B, Dorfler P, Aguzzi A, et al. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 1992;6:1589-607.
22. Stuart ET, Gruss P. What's new in developmental biology and cancer. Hum Mol Genet 1995;4:1717-20.
23. Maged SM, Naihui H, Masahara N, et al. Altered expression of PAX-5 gene in human myeloma cells. Blood 1996;87:4311-15.
24. Urbanek P, Wang ZQ, Fetka I, et al. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax-5/BSAP. Cell 1994;79:901-12.
25. Nutt SL, Thevenin C, Busslinger M. Essential functions of Pax-5 (BSAP) in pro-B cell development. Immunobiology 1997;198:227-35.